Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
ProgenaBiome
With
Microbiome Research Foundation
Patients with neurobastoma and concurrent dysbiosis showing a bifidobacteria-bacteroides gap will undergo fecal microbiota transplant as an adjunctive to standard-of-care oncology treatment.
Age
5–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
willingness of parent/guardian to sign ICF
diagnosis of neuroblastoma
dysbiosis of the gut microbiome
You may not be if
parent/guardian unwilling to sign ICF
dysbiosis does not show a bifidobaceteria-bacteroides gap
